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Thiamine deficiency, beriberi, and maternal and child health: 
why pharmacokinetics matter1–3
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In this issue of the Journal, Coats et al (1) describe short-term thiamine pharmacokinetics in 
nursing women from Cambodia who received a therapeutic course of oral thiamine for 5 d. 
Before supplementation, the mothers and infants were biochemically thiamine deficient. 
Treatment normalized thiamine status in the mothers but not in the infants, although 
thiamine concentrations in breast milk increased rapidly with supplementation. The authors 
characterized thiamine status in the mothers and their breastfed infants before and after 
thiamine administration and compared their findings with blood samples from healthy 
nursing American mothers who were age-matched to their Cambodian counterparts. The 
data provide important insights on the nutritional pathophysiology of thiamine depletion, 
repletion, and therapeutics and a sobering reminder that nutritional deficiency disease, 
including beriberi, persists as an important cause of morbidity and mortality globally. 
Several aspects of the study are worth further consideration, including the study design, the 
analytic approach used to assess thiamine status, and implications for global maternal and 
child health.
This study adds to the limited literature on pharmacokinetic data for thiamine; most of the 
previously published data come from healthy, well-nourished subjects (2). Coats et al used a 
standard approach to examine thiamine disposition in 16 healthy nursing Cambodian women 
from a district in Prey Vang Province, where previous work showed endemic thiamine 
deficiency among mothers and infants (1, 3). The thiamine dose used (100 mg thiamine 
hydrochloride tablet/d for 5 d, 500 mg total), although far above the Recommended Dietary 
Allowance (1.4 mg/d for lactating women) and higher than the usual therapeutic regimen for 
“mild” thiamine deficiency (5–30 mg/d in single or divided doses for 1 mo), was similar to 
doses typically used for severe deficiency [≤300 mg/d (4)] and within the range used in a 
previous pharmacokinetics study (2). The present study shows high maternal bioavailability 
of this pharmacologic dose but only modest improvements in the thiamine status of the 
infants after 5 d of maternal treatment. The authors appropriately note that supplementation 
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for longer periods or with higher or more frequent doses should be considered and, most 
importantly, that symptomatic infants should be treated directly (1).
The findings of Coats et al indicate rapid normalization of circulating maternal plasma 
thiamine and thiamine monophosphate by day 6, and rapid normalization of breast-milk 
thiamine, but slower normalization of blood thiamine diphosphate (1). The information on 
breast-milk thiamine is of great value in a thiamine-deficient population and provides unique 
data to estimate the benefit to the infant if only the mother receives supplementation, data 
that were not available previously. A recent report on a longer-term thiamine 
supplementation regimen (100 mg/d during pregnancy and lactation) at antenatal clinics in a 
refugee camp showed that thiamine status in lactating women 12 wk postpartum was within 
the range observed in well-nourished women and that thiamine measurements in breast milk 
provided useful information on maternal thiamine status (5).
The analytic approach used to assess thiamine status has evolved over time. The traditional 
indirect approach, not used in this study but still in use (6), is to measure erythrocyte 
transketolase activity as a functional test that reflects the adequacy of body stores and is 
sensitive to marginal thiamine deficiency. However, advances in laboratory techniques and 
the availability of HPLC instrumentation have facilitated the use of the direct approach to 
measure thiamine and its phosphate esters by use of sensitive and specific fluorometric 
detection (1, 5, 7). Furthermore, this direct approach can be applied to a wide range of 
matrices (serum, whole blood or erythrocytes, urine, and breast milk) that are not all 
accessible to the functional test. Regardless of the approach, however, tests to assess 
thiamine status are not conducted widely enough to justify establishing an external 
proficiency testing program. It is therefore vital that each laboratory establishes its own 
internal quality assessment program to ensure high-quality measurements (8).
What factors account for the persistence of thiamine deficiency, especially in postpartum 
women and their breastfed infants? Despite recognition of its public health significance for 
>100 y, beriberi remains prevalent in Southeast Asia, where it has long been associated with 
consumption of polished rice and numerous foods containing antithiamine activity as well as 
alcohol and betel nut use (1, 3, 6, 9, 10). The work of Coats et al (1) serves to remind us, 
once again, of the persistence of thiamine deficiency as a maternal and child health problem. 
In 2001 McGready et al (9) reported a 57.7% prevalence of biochemical thiamine deficiency 
in a population of postpartum refugee women along the Thai-Burmese border. In 2011 
Khounnorath et al (10) and Lima et al (11) described biochemical thiamine deficiency in 
breastfed infants and critically ill children on admission in Vientiane, Laos, and Sao Paulo, 
Brazil, respectively.
The current study reminds us that the full spectrum of clinical thiamine deficiency, including 
beriberi, Wernicke encephalopathy, and even death, also occurs in situations other than 
primary nutritional deficiency or frank alcoholism. Some clinical causes include bariatric 
surgery (12) and prolonged administration of total parenteral nutrition without thiamine 
(13), which is a continuing challenge with shortages of parenteral multivitamin solutions 
(14).
Bowman et al. Page 2













Considering its short biological half-life, limited body reserves, constant metabolic demand 
particularly during periods of rapid growth, variable content and bioavailability in human 
diets, the clinically inapparent presentation of deficiency, as well as the profound clinical 
manifestations and adverse clinical outcomes that can develop quickly during chronic 
depletion, thiamine will likely continue to serve as a sentinel for nutritional deficiency and a 
harbinger for deficiency of other nutrients. Coats et al show that acute thiamine treatment, 
even with a pharmacologic dose, may be insufficient to replete thiamine stores in the 
maternal and infant dyad. Public health leaders should be alert to identify situations in which 
mothers and infants are at high risk of thiamine deficiency and ensure prompt initiation of 
treatment. In treating thiamine deficiency, clinicians can implement evidence-based 
supplementation protocols to maximize clinical benefit in postpartum women and their 
breastfed infants. These combined efforts can help to reduce and prevent beriberi worldwide 
by addressing the root cause, unrecognized thiamine deficiency. Greater recognition of the 
spectrum of thiamine deficiency should enable the supporting science to move beyond 
descriptive epidemiology to implement prevention and control in vulnerable populations 
worldwide.
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